cidofovir anhydrous has been researched along with DNA Virus Infections in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Clercq, E; Snoeck, R | 1 |
De Clercq, E | 3 |
Zabawski, EJ | 1 |
5 review(s) available for cidofovir anhydrous and DNA Virus Infections
Article | Year |
---|---|
Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients.
Topics: Cidofovir; Cytomegalovirus Infections; Cytosine; DNA Virus Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds | 2002 |
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
Topics: Adenine; Animals; Cidofovir; Cytosine; DNA Virus Infections; DNA Viruses; Humans; Organophosphonates; Organophosphorus Compounds; Retroviridae; Retroviridae Infections; Reverse Transcriptase Inhibitors; Tenofovir | 2003 |
Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.
Topics: Adenine; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; DNA Virus Infections; Drug Resistance, Viral; Humans; Organophosphonates; Organophosphorus Compounds; Retroviridae Infections; Tenofovir | 2003 |
Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections.
Topics: Adenine; Animals; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytosine; DNA Virus Infections; Humans; Organophosphonates; Organophosphorus Compounds; Retroviridae Infections | 1997 |
A review of topical and intralesional cidofovir.
Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; DNA Virus Infections; DNA Viruses; Humans; Injections, Intralesional; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Viral | 2000 |